Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,348 public trials 1,367 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Completed

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

NCT00051987

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +9 more
Locations
  • Cooper Green Hospital / Jefferson Clinic P.C. Birmingham, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Arkansas Cancer Center Pine Bluff, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkley, California, United States
View all 22 locations
View Trial Details
Completed

A Study of ABT-751 in Patients With Colorectal Cancer

NCT00073138

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cancer Institute Medical Group Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Clinical Trial in Patients With Metastatic Colorectal Cancer

NCT00081627

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Mercy General Hospital Sacramento, California, United States
  • VA San Diego Healthcare System San Diego, California, United States
  • Spectrum Health Grand Rapids, Michigan, United States
View Trial Details
Completed

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer

NCT00079872

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician NSW, QLD, South Australia, Victoria, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woodville, Australia
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Frankfurt am Main, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krete, Greece
View Trial Details

Related conditions